Evidence map›Paper›PMID 8929320›Full record

ReviewEuropean journal of nuclear medicine1996

Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucose.

P Rigo, P Paulus, B J Kaschten, R Hustinx, T Bury, G Jerusalem, T Benoit, J Foidart-Willems

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in European journal of nuclear medicine, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00537797 (Limited Neck FDG-PET Imaging for Indeterminate Thyroid Nodules), which is not on this map. Cited by 68 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00537797 nacompletednot on this mapstarted 2004, after this paper: background citation

Limited Neck FDG-PET Imaging for Indeterminate Thyroid Nodules

TypeinterventionalSponsorWashington University School of MedicineRan2004 to 2014Enrolled84ConditionsThyroid NeoplasmsArmsFDG-PET Scan
3 · Its place in the literature

Who cites it

68 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Abdominal radiology (New York) · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. IncidentalEuropean journal of nuclear medicine and molecular imaging · 2020
    Article
  16. Review
  17. Review
  18. Glucose-6-phosphatase Expression-Mediated [Molecular imaging and biology · 2019
    Article
  19. Beyond T2 and 3T: New MRI techniques for clinicians.Clinical and translational radiation oncology · 2019
    Review
  20. Review

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

P RigoDivision of Nuclear Medicine, University Hospital, Sart Tilman, Liege, Belgium.
P Paulus
B J Kaschten
R Hustinx
T Bury
G Jerusalem
T Benoit
J Foidart-Willems

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Positron emission tomography (PET) is now primarily used in oncological indication owing to the successful application of fluorine-18 fluorodeoxyglucose (FDG) in an increasing number of clinical indications at different stages of diagnosis, and for staging and follow-up. This review first considers the biological characteristics of FDG and then discusses methodological considerations regarding its use. Clinical indications are considered, and the results achieved in respect of various organs and tumour types are reviewed in depth. The review concludes with a brief consideration of the ways in which clinical PET might be improved.

Indexed as

Fluorine RadioisotopesTomography, Emission-ComputedDeoxyglucoseFluorodeoxyglucose F18HumansNeoplasmsDeoxyglucoseFluorine RadioisotopesFluorodeoxyglucose F18

Identifiers

PMID8929320

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.